Cargando…
A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis
An 82-year-old man presented with intermittent episodes of slurred speech during his evening meals after receiving the BNT162b2 COVID-19 vaccine. Thorough evaluation was conducted including lab work and EMG confirming a new diagnosis of late-onset myasthenia gravis. Despite treatment, the patient pr...
Autores principales: | Chavez, Augustine, Pougnier, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559213/ https://www.ncbi.nlm.nih.gov/pubmed/34709075 http://dx.doi.org/10.1177/21501327211051933 |
Ejemplares similares
-
Covid-19-vaccine-pfizer-biontech: Myasthenia gravis: case report
Publicado: (2022) -
“A new case of myasthenia gravis following COVID-19 Vaccination”
por: Abna, Zohreh, et al.
Publicado: (2022) -
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Lee, Myung Ah, et al.
Publicado: (2022) -
New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022) -
Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)